TELA Bio, Inc. (TELA) Misses Q1 EPS by 9c

TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.91 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
• Worthington Industries (WOR) Misses Q4 EPS by 9c